
A data-driven strategy can assess the quality of legacy drugs developed before 2011 process-validation requirements were established.
Sanjay Sharma is vice-president and head of technology transfer at Lupin Pharmaceuticals

A data-driven strategy can assess the quality of legacy drugs developed before 2011 process-validation requirements were established.

Published: July 2nd 2021 | Updated: